News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
188,702 Results
Type
Article (9173)
Company Profile (23)
Press Release (179506)
Multimedia
Podcasts (2)
Webinars (1)
Section
Business (58913)
Career Advice (655)
Deals (11187)
Drug Delivery (21)
Drug Development (28999)
Employer Resources (40)
FDA (4948)
Job Trends (4560)
News (101785)
Policy (8097)
Tag
Academia (503)
Accelerated approval (2)
Adcomms (5)
Allergies (40)
Alliances (7846)
ALS (50)
Alzheimer's disease (552)
Antibody-drug conjugate (ADC) (53)
Approvals (5010)
Artificial intelligence (134)
Autoimmune disease (18)
Automation (8)
Bankruptcy (78)
Best Places to Work (4095)
BIOSECURE Act (3)
Biosimilars (56)
Biotechnology (22)
Bladder cancer (58)
Brain cancer (12)
Breast cancer (193)
Cancer (1322)
Cardiovascular disease (87)
Career advice (532)
Career pathing (7)
CAR-T (55)
Cell therapy (169)
Cervical cancer (12)
Clinical research (25545)
Collaboration (394)
Company closure (1)
Compensation (274)
COVID-19 (830)
CRISPR (18)
C-suite (89)
Cystic fibrosis (38)
Data (1427)
Depression (22)
Diabetes (132)
Diagnostics (1823)
Digital health (7)
Diversity, equity & inclusion (10)
Drug discovery (44)
Drug pricing (27)
Drug shortages (11)
Duchenne muscular dystrophy (58)
Earnings (45030)
Editorial (13)
Employer branding (8)
Employer resources (34)
Events (27986)
Executive appointments (328)
FDA (5709)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (367)
Gene editing (42)
Generative AI (4)
Gene therapy (140)
GLP-1 (329)
Government (1143)
Grass and pollen (3)
Guidances (139)
Healthcare (5294)
Huntington's disease (5)
IgA nephropathy (10)
Immunology and inflammation (55)
Indications (18)
Infectious disease (898)
Inflammatory bowel disease (58)
Inflation Reduction Act (2)
Influenza (23)
Intellectual property (35)
Interviews (125)
IPO (7135)
IRA (13)
Job creations (783)
Job search strategy (462)
Kidney cancer (9)
Labor market (12)
Layoffs (128)
Leadership (3)
Legal (1474)
Liver cancer (29)
Lung cancer (205)
Lymphoma (100)
Machine learning (4)
Management (10)
Manufacturing (110)
MASH (39)
Medical device (4039)
Medtech (4039)
Mergers & acquisitions (4404)
Metabolic disorders (337)
Multiple sclerosis (57)
NASH (6)
Neurodegenerative disease (46)
Neuropsychiatric disorders (17)
Neuroscience (833)
NextGen: Class of 2025 (1482)
Non-profit (1048)
Now hiring (4)
Obesity (166)
Opinion (43)
Ovarian cancer (37)
Pain (40)
Pancreatic cancer (46)
Parkinson's disease (77)
Partnered (3)
Patents (100)
Patient recruitment (47)
Peanut (19)
People (6698)
Pharmaceutical (6)
Pharmacy benefit managers (6)
Phase I (6591)
Phase II (10983)
Phase III (10002)
Pipeline (1020)
Policy (29)
Postmarket research (1068)
Preclinical (2056)
Press Release (27)
Prostate cancer (63)
Psychedelics (4)
Radiopharmaceuticals (80)
Rare diseases (162)
Real estate (890)
Recruiting (15)
Regulatory (6346)
Reports (13)
Research institute (487)
Resumes & cover letters (111)
Rett syndrome (4)
RNA editing (1)
RSV (22)
Schizophrenia (42)
Series A (57)
Series B (44)
Service/supplier (3)
Sickle cell disease (27)
Special edition (5)
Spinal muscular atrophy (86)
Sponsored (7)
Startups (631)
State (1)
Stomach cancer (5)
Supply chain (41)
Tariffs (12)
The Weekly (2)
Vaccines (291)
Venture capitalists (15)
Weight loss (109)
Women's health (10)
Worklife (8)
Date
Today (15)
Last 7 days (637)
Last 30 days (1762)
Last 365 days (16242)
2025 (6703)
2024 (14760)
2023 (14315)
2022 (16776)
2021 (16234)
2020 (15541)
2019 (12785)
2018 (9784)
2017 (9333)
2016 (7966)
2015 (9632)
2014 (7086)
2013 (5215)
2012 (5911)
2011 (6161)
2010 (5233)
Location
Africa (216)
Alabama (11)
Alaska (2)
Arizona (49)
Arkansas (5)
Asia (12044)
Australia (2098)
California (3277)
Canada (871)
China (267)
Colorado (146)
Connecticut (178)
Delaware (120)
Europe (29365)
Florida (383)
Georgia (84)
Idaho (10)
Illinois (242)
India (10)
Indiana (145)
Iowa (6)
Japan (119)
Kansas (48)
Kentucky (9)
Louisiana (5)
Maine (35)
Maryland (348)
Massachusetts (2447)
Michigan (70)
Minnesota (169)
Missouri (39)
Montana (11)
Nebraska (4)
Nevada (34)
New Hampshire (27)
New Jersey (960)
New Mexico (5)
New York (888)
North Carolina (459)
North Dakota (2)
Northern California (1463)
Ohio (82)
Oklahoma (4)
Oregon (10)
Pennsylvania (628)
Puerto Rico (2)
Rhode Island (11)
South America (321)
South Carolina (8)
Southern California (1205)
Tennessee (46)
Texas (468)
United States (11666)
Utah (78)
Virginia (80)
Washington D.C. (30)
Washington State (294)
West Virginia (2)
Wisconsin (47)
188,702 Results for "6".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Baxter Declares Quarterly Dividend - May 6, 2025
May 7, 2025
·
1 min read
Press Releases
Uviquity Emerges from Stealth with $6.6M Seed Funding to Develop Breakthrough Far-UVC Semiconductor Technology for Human-Safe Photonic Disinfection
May 7, 2025
·
3 min read
Compensation
Top 6 Highest-Paid Pharma CEOs in 2024
Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.
April 16, 2025
·
7 min read
·
Annalee Armstrong
Press Releases
Candel Therapeutics to Present at Upcoming Investor Conferences - May 6, 2025
May 7, 2025
·
4 min read
Press Releases
Cytokinetics to Announce First Quarter Results on May 6, 2025
April 23, 2025
·
3 min read
Spinal muscular atrophy
6 Therapies on the Horizon for Spinal Muscular Atrophy
Since 2016, the FDA has approved three disease-modifying treatments for spinal muscular atrophy, with several companies—including Novartis, Scholar Rock and Biogen—progressing novel candidates through clinical trials.
March 24, 2025
·
5 min read
·
Natalia Mesa
Job Trends
6 Companies Hiring in Pennsylvania
Looking for a biopharma job in Pennsylvania? Check out the
BioSpace
list of six companies hiring life sciences professionals like you.
February 20, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences - May 6, 2025
May 7, 2025
·
7 min read
Press Releases
IQVIA to Announce First-Quarter 2025 Results on May 6, 2025
April 22, 2025
·
2 min read
Press Releases
Evotec SE to Announce Results for the First Quarter 2025 on 6 May 2025
April 29, 2025
·
3 min read
1 of 18,871
Next
